0001209191-19-005618.txt : 20190128
0001209191-19-005618.hdr.sgml : 20190128
20190128174507
ACCESSION NUMBER: 0001209191-19-005618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190124
FILED AS OF DATE: 20190128
DATE AS OF CHANGE: 20190128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Macrae Sandy
CENTRAL INDEX KEY: 0001675687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 19546638
MAIL ADDRESS:
STREET 1: 721 ST. GEORGES ROAD
CITY: PHILADELPHIA
STATE: PA
ZIP: 19119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-24
0
0001001233
SANGAMO THERAPEUTICS, INC
SGMO
0001675687
Macrae Sandy
501 CANAL BLVD.
RICHMOND
CA
94804
1
1
0
0
President and CEO
Common Stock
2018-01-24
4
F
0
3974
11.10
D
27526
D
Represents shares underlying the portion of the restricted stock unit grant that vested on January 24, 2019 surrendered by the Reporting Person to
the Issuer for tax withholding, using the Issuer's closing stock price on January 24, 2019 of $11.10/share, pursuant to the terms of the Issuer's 2013
Stock Incentive Plan.
Includes 6,526 shares resulting from the January 24, 2019 vesting of Reporting Person's January 24, 2018 restricted stock unit grant and 21,000
shares subject to such restricted stock unit grant that will vest in two (2) additional equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer
through such date.
Denise Winn, Attorney-in-Fact for Sandy Macrae
2019-01-28